FDA Inspection 1064090 — Jubilant Cadista Pharmaceuticals

Jubilant Cadista Pharmaceuticals — FEI 3017221809

The FDA completed an inspection of Jubilant Cadista Pharmaceuticals on May 4, 2018 in Yardley, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
May 4, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yardley, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.